4-[[(1R,3aS,5aR,5bR,7aR,9S,11aR,11bR,13aR,13bR)-3a-[3-[[(E)-3-(1,3-benzodioxol-5-yl)prop-2-enoyl]amino]propylcarbamoyl]-5a,5b,8,8,11a-pentamethyl-1-prop-1-en-2-yl-1,2,3,4,5,6,7,7a,9,10,11,11b,12,13,13a,13b-hexadecahydrocyclopenta[a]chrysen-9-yl]oxy]-2,2-dimethyl-4-oxobutanoic acid

C49H70N2O8 — CID 162645118

IUPAC4-[[(1R,3aS,5aR,5bR,7aR,9S,11aR,11bR,13aR,13bR)-3a-[3-[[(E)-3-(1,3-benzodioxol-5-yl)prop-2-enoyl]amino]propylcarbamoyl]-5a,5b,8,8,11a-pentamethyl-1-prop-1-en-2-yl-1,2,3,4,5,6,7,7a,9,10,11,11b,12,13,13a,13b-hexadecahydrocyclopenta[a]chrysen-9-yl]oxy]-2,2-dimethyl-4-oxobutanoic acid
SMILESC=C(C)[C@@H]1CC[C@]2(C(=O)NCCCNC(=O)/C=C/c3ccc4c(c3)OCO4)CC[C@]3(C)[C@H](CC[C@@H]4[C@@]5(C)CC[C@H](OC(=O)CC(C)(C)C(=O)O)C(C)(C)[C@@H]5CC[C@]43C)[C@@H]12
InChIInChI=1S/C49H70N2O8/c1-30(2)32-17-22-49(42(54)51-26-10-25-50-39(52)16-12-31-11-14-34-35(27-31)58-29-57-34)24-23-47(8)33(41(32)49)13-15-37-46(7)20-19-38(59-40(53)28-44(3,4)43(55)56)45(5,6)36(46)18-21-48(37,47)9/h11-12,14,16,27,32-33,36-38,41H,1,10,13,15,17-26,28-29H2,2-9H3,(H,50,52)(H,51,54)(H,55,56)/b16-12+/t32-,33+,36-,37+,38-,41+,46-,47+,48+,49-/m0/s1
InChIKeyUYTNVPVFXIDBEO-LUNONQFTSA-N
MW815.10 g/mol
LogP9.12
Rot. Bonds12

About 4-[[(1R,3aS,5aR,5bR,7aR,9S,11aR,11bR,13aR,13bR)-3a-[3-[[(E)-3-(1,3-benzodioxol-5-yl)prop-2-enoyl]amino]propylcarbamoyl]-5a,5b,8,8,11a-pentamethyl-1-prop-1-en-2-yl-1,2,3,4,5,6,7,7a,9,10,11,11b,12,13,13a,13b-hexadecahydrocyclopenta[a]chrysen-9-yl]oxy]-2,2-dimethyl-4-oxobutanoic acid

4-[[(1R,3aS,5aR,5bR,7aR,9S,11aR,11bR,13aR,13bR)-3a-[3-[[(E)-3-(1,3-benzodioxol-5-yl)prop-2-enoyl]amino]propylcarbamoyl]-5a,5b,8,8,11a-pentamethyl-1-prop-1-en-2-yl-1,2,3,4,5,6,7,7a,9,10,11,11b,12,13,13a,13b-hexadecahydrocyclopenta[a]chrysen-9-yl]oxy]-2,2-dimethyl-4-oxobutanoic acid (PubChem CID 162645118) has the molecular formula C49H70N2O8 and a molecular weight of 815.10 g/mol. Its IUPAC name is 4-[[(1R,3aS,5aR,5bR,7aR,9S,11aR,11bR,13aR,13bR)-3a-[3-[[(E)-3-(1,3-benzodioxol-5-yl)prop-2-enoyl]amino]propylcarbamoyl]-5a,5b,8,8,11a-pentamethyl-1-prop-1-en-2-yl-1,2,3,4,5,6,7,7a,9,10,11,11b,12,13,13a,13b-hexadecahydrocyclopenta[a]chrysen-9-yl]oxy]-2,2-dimethyl-4-oxobutanoic acid.

Molecular Properties

Compound Name4-[[(1R,3aS,5aR,5bR,7aR,9S,11aR,11bR,13aR,13bR)-3a-[3-[[(E)-3-(1,3-benzodioxol-5-yl)prop-2-enoyl]amino]propylcarbamoyl]-5a,5b,8,8,11a-pentamethyl-1-prop-1-en-2-yl-1,2,3,4,5,6,7,7a,9,10,11,11b,12,13,13a,13b-hexadecahydrocyclopenta[a]chrysen-9-yl]oxy]-2,2-dimethyl-4-oxobutanoic acid
PubChem CID162645118
Molecular FormulaC49H70N2O8
Molecular Weight815.10 g/mol
Exact Mass814.51
IUPAC Name4-[[(1R,3aS,5aR,5bR,7aR,9S,11aR,11bR,13aR,13bR)-3a-[3-[[(E)-3-(1,3-benzodioxol-5-yl)prop-2-enoyl]amino]propylcarbamoyl]-5a,5b,8,8,11a-pentamethyl-1-prop-1-en-2-yl-1,2,3,4,5,6,7,7a,9,10,11,11b,12,13,13a,13b-hexadecahydrocyclopenta[a]chrysen-9-yl]oxy]-2,2-dimethyl-4-oxobutanoic acid
SMILESC=C(C)[C@@H]1CC[C@]2(C(=O)NCCCNC(=O)/C=C/c3ccc4c(c3)OCO4)CC[C@]3(C)[C@H](CC[C@@H]4[C@@]5(C)CC[C@H](OC(=O)CC(C)(C)C(=O)O)C(C)(C)[C@@H]5CC[C@]43C)[C@@H]12
InChIInChI=1S/C49H70N2O8/c1-30(2)32-17-22-49(42(54)51-26-10-25-50-39(52)16-12-31-11-14-34-35(27-31)58-29-57-34)24-23-47(8)33(41(32)49)13-15-37-46(7)20-19-38(59-40(53)28-44(3,4)43(55)56)45(5,6)36(46)18-21-48(37,47)9/h11-12,14,16,27,32-33,36-38,41H,1,10,13,15,17-26,28-29H2,2-9H3,(H,50,52)(H,51,54)(H,55,56)/b16-12+/t32-,33+,36-,37+,38-,41+,46-,47+,48+,49-/m0/s1
InChIKeyUYTNVPVFXIDBEO-LUNONQFTSA-N
XLogP9.12
TPSA140.26 Ų
H-Bond Donors3
H-Bond Acceptors7
Rotatable Bonds12
Heavy Atoms59
Complexity

Lipinski Rule of Five

2 violations

RuleValue
MW ≤ 500815.10
LogP ≤ 59.12
H-Bond Donors ≤ 53
H-Bond Acceptors ≤ 107

Computed Properties (RDKit)

Structural Alerts{'alert_name': 'Aliphatic_long_chain', 'substructure': 'N/A'}, {'alert_name': 'isolated_alkene', 'substructure': 'N/A'}, {'alert_name': 'Michael_acceptor_1', 'substructure': 'N/A'}

Analyze 4-[[(1R,3aS,5aR,5bR,7aR,9S,11aR,11bR,13aR,13bR)-3a-[3-[[(E)-3-(1,3-benzodioxol-5-yl)prop-2-enoyl]amino]propylcarbamoyl]-5a,5b,8,8,11a-pentamethyl-1-prop-1-en-2-yl-1,2,3,4,5,6,7,7a,9,10,11,11b,12,13,13a,13b-hexadecahydrocyclopenta[a]chrysen-9-yl]oxy]-2,2-dimethyl-4-oxobutanoic acid with MolForge

Explore ADMET properties, 3D molecular structure, drug-likeness score, and discover similar compounds using our AI-powered platform.

Launch Full Analysis

Related Compounds

Frequently Asked Questions

What is the IUPAC name of 4-[[(1R,3aS,5aR,5bR,7aR,9S,11aR,11bR,13aR,13bR)-3a-[3-[[(E)-3-(1,3-benzodioxol-5-yl)prop-2-enoyl]amino]propylcarbamoyl]-5a,5b,8,8,11a-pentamethyl-1-prop-1-en-2-yl-1,2,3,4,5,6,7,7a,9,10,11,11b,12,13,13a,13b-hexadecahydrocyclopenta[a]chrysen-9-yl]oxy]-2,2-dimethyl-4-oxobutanoic acid?
The IUPAC name of 4-[[(1R,3aS,5aR,5bR,7aR,9S,11aR,11bR,13aR,13bR)-3a-[3-[[(E)-3-(1,3-benzodioxol-5-yl)prop-2-enoyl]amino]propylcarbamoyl]-5a,5b,8,8,11a-pentamethyl-1-prop-1-en-2-yl-1,2,3,4,5,6,7,7a,9,10,11,11b,12,13,13a,13b-hexadecahydrocyclopenta[a]chrysen-9-yl]oxy]-2,2-dimethyl-4-oxobutanoic acid (CID 162645118) is 4-[[(1R,3aS,5aR,5bR,7aR,9S,11aR,11bR,13aR,13bR)-3a-[3-[[(E)-3-(1,3-benzodioxol-5-yl)prop-2-enoyl]amino]propylcarbamoyl]-5a,5b,8,8,11a-pentamethyl-1-prop-1-en-2-yl-1,2,3,4,5,6,7,7a,9,10,11,11b,12,13,13a,13b-hexadecahydrocyclopenta[a]chrysen-9-yl]oxy]-2,2-dimethyl-4-oxobutanoic acid.
What is the SMILES notation for 4-[[(1R,3aS,5aR,5bR,7aR,9S,11aR,11bR,13aR,13bR)-3a-[3-[[(E)-3-(1,3-benzodioxol-5-yl)prop-2-enoyl]amino]propylcarbamoyl]-5a,5b,8,8,11a-pentamethyl-1-prop-1-en-2-yl-1,2,3,4,5,6,7,7a,9,10,11,11b,12,13,13a,13b-hexadecahydrocyclopenta[a]chrysen-9-yl]oxy]-2,2-dimethyl-4-oxobutanoic acid?
The canonical SMILES for 4-[[(1R,3aS,5aR,5bR,7aR,9S,11aR,11bR,13aR,13bR)-3a-[3-[[(E)-3-(1,3-benzodioxol-5-yl)prop-2-enoyl]amino]propylcarbamoyl]-5a,5b,8,8,11a-pentamethyl-1-prop-1-en-2-yl-1,2,3,4,5,6,7,7a,9,10,11,11b,12,13,13a,13b-hexadecahydrocyclopenta[a]chrysen-9-yl]oxy]-2,2-dimethyl-4-oxobutanoic acid is C=C(C)[C@@H]1CC[C@]2(C(=O)NCCCNC(=O)/C=C/c3ccc4c(c3)OCO4)CC[C@]3(C)[C@H](CC[C@@H]4[C@@]5(C)CC[C@H](OC(=O)CC(C)(C)C(=O)O)C(C)(C)[C@@H]5CC[C@]43C)[C@@H]12.
What is the InChIKey of 4-[[(1R,3aS,5aR,5bR,7aR,9S,11aR,11bR,13aR,13bR)-3a-[3-[[(E)-3-(1,3-benzodioxol-5-yl)prop-2-enoyl]amino]propylcarbamoyl]-5a,5b,8,8,11a-pentamethyl-1-prop-1-en-2-yl-1,2,3,4,5,6,7,7a,9,10,11,11b,12,13,13a,13b-hexadecahydrocyclopenta[a]chrysen-9-yl]oxy]-2,2-dimethyl-4-oxobutanoic acid?
The InChIKey is UYTNVPVFXIDBEO-LUNONQFTSA-N. The full InChI is InChI=1S/C49H70N2O8/c1-30(2)32-17-22-49(42(54)51-26-10-25-50-39(52)16-12-31-11-14-34-35(27-31)58-29-57-34)24-23-47(8)33(41(32)49)13-15-37-46(7)20-19-38(59-40(53)28-44(3,4)43(55)56)45(5,6)36(46)18-21-48(37,47)9/h11-12,14,16,27,32-33,36-38,41H,1,10,13,15,17-26,28-29H2,2-9H3,(H,50,52)(H,51,54)(H,55,56)/b16-12+/t32-,33+,36-,37+,38-,41+,46-,47+,48+,49-/m0/s1.
What are the key properties of 4-[[(1R,3aS,5aR,5bR,7aR,9S,11aR,11bR,13aR,13bR)-3a-[3-[[(E)-3-(1,3-benzodioxol-5-yl)prop-2-enoyl]amino]propylcarbamoyl]-5a,5b,8,8,11a-pentamethyl-1-prop-1-en-2-yl-1,2,3,4,5,6,7,7a,9,10,11,11b,12,13,13a,13b-hexadecahydrocyclopenta[a]chrysen-9-yl]oxy]-2,2-dimethyl-4-oxobutanoic acid?
4-[[(1R,3aS,5aR,5bR,7aR,9S,11aR,11bR,13aR,13bR)-3a-[3-[[(E)-3-(1,3-benzodioxol-5-yl)prop-2-enoyl]amino]propylcarbamoyl]-5a,5b,8,8,11a-pentamethyl-1-prop-1-en-2-yl-1,2,3,4,5,6,7,7a,9,10,11,11b,12,13,13a,13b-hexadecahydrocyclopenta[a]chrysen-9-yl]oxy]-2,2-dimethyl-4-oxobutanoic acid has a molecular weight of 815.10 g/mol, XLogP of 9.12, 12 rotatable bonds, 3 hydrogen bond donors, and 7 hydrogen bond acceptors.
Where does this data come from?
All data for 4-[[(1R,3aS,5aR,5bR,7aR,9S,11aR,11bR,13aR,13bR)-3a-[3-[[(E)-3-(1,3-benzodioxol-5-yl)prop-2-enoyl]amino]propylcarbamoyl]-5a,5b,8,8,11a-pentamethyl-1-prop-1-en-2-yl-1,2,3,4,5,6,7,7a,9,10,11,11b,12,13,13a,13b-hexadecahydrocyclopenta[a]chrysen-9-yl]oxy]-2,2-dimethyl-4-oxobutanoic acid is sourced from PubChem (CID 162645118), the world's largest open chemistry database maintained by the National Library of Medicine (NIH).